"Designing Growth Strategies is in our DNA"

Non-Surgical Cosmetic Procedures Market Size, Share & Industry Analysis, By Procedure (Botulinum Toxin, Hyaluronic Acid, Hair Removal, Non-surgical Fat Reduction, Photo Rejuvenation, and Others), By Gender (Female and Male), By Age Group (18 Years & Younger, 19 to 34 Years, 35 to 50 Years, 51 to 64 Years, and 65 Years and Above), By Provider (Hospitals & Specialty Clinics and Spas & Cosmetic Surgery Centers), and Regional Forecast, 2025-2032

Last Updated: December 15, 2025 | Format: PDF | Report ID: FBI113627

 

KEY MARKET INSIGHTS

Play Audio Listen to Audio Version

The global non-surgical cosmetic procedures market size was valued at USD 11.53 billion in 2024. The market is projected to grow from USD 12.19 billion in 2025 to USD 18.08 billion by 2032, exhibiting a CAGR of 5.8% during the forecast period. North America dominated the non-surgical cosmetic procedures market with a market share of 49.60% in 2024.

Non-surgical cosmetic procedures improve an individual’s appearance without surgery, commonly called medspa or medical spa procedures. These procedures include treatments including Botox, fillers, chemical peels, microdermabrasion, laser treatments, and various skin tightening techniques using ultrasound and radiofrequency devices. It reduces wrinkles, improves skin texture, and addresses other cosmetic concerns.

The market growth is driven by an increasing preference for minimally invasive procedures, a rising aging population, increasing awareness about aesthetic procedures, and rising disposable income & beauty consciousness. Furthermore, the market consists of several small and mid-size companies including AbbVie, REVANCE MERZ AESTHETICS, WiQo S.p.A., GALDERMA, and Sinclair, among others. These players are focusing on forming strategic alliances to enhance their product offerings in the global market.

  • For instance, in April 2025, Emcutix Biopharmaceuticals inked an exclusive in-licensing agreement with WiQo S.p.A., an innovative Italian derma-cosmetic and medical device company specializing in scientifically validated products. The strategic partnership granted Emcutix Biopharmaceuticals the rights to import, promote, distribute, and sell WiQo's ground-breaking product PRX-PLUS in India.

MARKET DYNAMICS

Market Drivers

High Burden of Skin Disorders and Rising Number of Non-Surgical Cosmetic Procedures Drive Market Growth

The growing number of incidences related to skin disorders globally drives the non-surgical cosmetic procedures market growth. Skin conditions such as acne, hyperpigmentation, cellulite, and melasma impact physical appearance and have an intense psychological effect on individuals, leading to decreased self-esteem and confidence. As a result, people undergo minimally invasive cosmetic treatments to manage the visible symptoms of these disorders and improve their skin appearance. Procedures such as laser therapies, chemical peels, and intense pulsed light treatments are becoming progressively popular due to their ability to provide effective outcomes.

  • For example, as per the data provided by the American Academy of Dermatology Association in February 2025, acne is the most common skin condition in the U.S., affecting up to 50.0 million Americans annually.

Moreover, the rising number of non-surgical cosmetic procedures is significantly contributing to the growth of the market. As more individuals seek aesthetic enhancements without the risks of surgery, the demand for non-invasive cosmetic procedures has surged. This includes procedures such as Botox injections, chemical peels, and laser skin treatments, which offer faster results with fewer complications. The rising preference for these low-risk treatment options is increasing patient volumes and encouraging clinics and medical spas to expand their service offerings.

  • For example, as per the data provided by International Society of Aesthetic Plastic Surgery in June 2024, around 89,186 and 7,975 Botox and chemical peel procedures were performed in 2023 across the globe.

Market Restraints

Side Effects Associated with Cosmetic Procedures and Rising False Practices by B2C Platforms are Hindering Market Growth

Botox is the most common cosmetic procedure performed worldwide, with approximately 3.0 million injections estimated to take place each year. Most reported side effects include pain, swelling, or mild bruising at the injection site, a headache, and flu-like symptoms for the first 24 hours.

Additionally, few severe reactions were also observed in the past few years. For example, in April 2024, the U.S. Centers for Disease Control and Prevention (CDC) released an alert cautioning that 22 women aged between 25 to 59 years had reported "harmful reactions" to counterfeit or mishandled botox. Moreover, a total of 11 people were hospitalized, and 6 were treated with an antitoxin due to concerns of botulism (a condition where the toxin spreads beyond the local site and attacks the central nervous system, causing muscle paralysis, difficulty breathing, and even death).

Reported symptoms included blurry vision, difficulty breathing, difficulty swallowing, slurred speech, and weakness. All these 22 cases took place after the women received botox injections from unlicensed people in places with no or minimum healthcare settings. Furthermore, the products used to perform non-surgical cosmetic procedures are being illegally imported and distributed online by immoral suppliers, raising significant patient safety concerns. Therefore, the side effects of cosmetic products and illegal import and export of these products limit their adoption among consumers.

Market Opportunities

Growing Awareness About Non-surgical Cosmetic Procedures through Campaigns to Propel Market Development

Market players focus on organizing campaigns to create awareness among consumers regarding the benefits, safety, and efficacy of minimally invasive cosmetic procedures, creating growth opportunities for market players. In addition, the companies are also showcasing their cosmetic product portfolio in awareness campaigns to create brand awareness among consumers.

  • For example, in April 2025, Evolus, Inc. announced the launch of its new campaign, "Drop the F Word," ahead of the upcoming commercial launch of Evolysse. This campaign was organized to challenge outdated perceptions in the aesthetics industry. Also, during the campaign, the company introduced Evolysse, a collection of injectable hyaluronic acid (HA) gels used to treat moderate to severe facial wrinkles and nasolabial folds. This campaign reenergized the injectable HA category and addressed growing filler fatigue."
  • Also, in February 2019, Allergan Aesthetics, an AbbVie company, launched a new direct-to-consumer campaign for Botox Cosmetic (onabotulinumtoxinA) entitled "Own Your Look." The campaign was designed to address the most common concerns around Botox cosmetics, the fear of looking unnatural, and to encourage people to own their looks and aesthetic choices.

Market Challenges

High Cost of Non-surgical Cosmetic Treatments in Developed Countries Restricts Market Expansion

The non-surgical cosmetic procedures are expensive in developed nations, including the U.S. and the U.K., compared to Turkey, Mexico, Thailand, and other countries. This is due to various factors, including the cost of the medication, the provider's expertise, geographic location, and the demand for cosmetic procedures. These are a few major challenges faced by market players in recent years.

  • For example, as per the data provided by Dr. Cat Plastic Surgery, a cosmetic surgery clinic located in California, U.S., the botox treatments range from USD 100.0 to USD 2,800.0. On average, a Botox treatment is around USD 300.0 to USD 600.0, with the average Botox cost per unit at USD 10.0 to USD 18.0. Most of the treatments require around 30 to 40 units.
  • Similarly, the National Health Service (NHS), the term for the publicly funded healthcare system, provided the botox prices range between USD 127.7 to USD 447.0 in the U.K.

NON-SURGICAL COSMETIC PROCEDURES MARKET TRENDS

Growing Medical Tourism for Non-surgical Cosmetic Treatments in Developing Nations

The rising demand for minimally invasive surgeries, lower cost of these treatments in some countries, and convenience of treatments are some of the important factors enhancing market growth. Turkey, Mexico, Thailand, and several other countries are preferred locations for botox and other cosmetic procedures for the past few years. This is due to high-quality treatments and affordable pricing provided by these nations for botox and fillers. Additionally, the developing nations have advanced clinics with state-of-the-art equipment for cosmetic procedures that attract more individuals for aesthetic procedures including dermal fillers, botox, facelifts, and laser skin rejuvenation.

  • For example, according to Flymed International, more than 1.0 million medical tourists visit Turkey annually for cosmetic procedures as the cost of treatment is lower in this nation. The average botox cost per unit in Turkey is USD 3.0 to USD 5.0. On the other hand, the average botox cost per unit ranges from USD 15.0 to USD 25.0 in Europe.
  • Similarly, South Korea built its status as the global capital of beauty tourism by attracting over 100,000 international visitors annually for cosmetic procedures and skincare treatments. The country's medical tourism industry is booming with its pioneering aesthetic innovations and the influence of K-beauty trends.

Download Free sample to learn more about this report.

SEGMENTATION ANALYSIS

By Procedure

Botulinum Toxin Procedure Leads Due to its High Adoption Rate among a Larger Population

Based on procedure, the market is divided into botulinum toxin, hyaluronic acid, hair removal, non-surgical fat reduction, photo rejuvenation, and others.

The botulinum toxin segment dominated the global market in 2024 and is anticipated to grow at a considerable CAGR during the forecast period. The segment's growth is primarily attributed to the higher number of people undergoing Botox treatment to efficiently reduce wrinkles & fine lines, improving skin texture and elasticity.

  • For instance, as per the data provided by the International Society of Aesthetic Plastic Surgery in June 2024, around 2.5 million people went for Botox treatment in the U.S. in 2023.

On the other hand, the non-surgical fat reduction segment is anticipated to grow at the highest CAGR during the forecast period, owing to the high rate of obesity and the growing demand for aesthetic procedures across the globe.

  • For example, as per the World Obesity Atlas 2024 report published in March 2024, around 0.81 billion adults were living with obesity worldwide in 2020. This number is expected to increase to 1.01 billion by the end of 2025.

Furthermore, the hyaluronic acid segment is expected to grow at the second-largest CAGR from 2025-2032. The segment's growth is mainly attributed to the rising number of people undergoing hyaluronic acid treatments to improve their appearance.

By Gender

Female Gender Leads Owing to their Higher Number Undergoing Cosmetic Procedures

Based on gender, the market is divided into female and male.

The female segment is projected to hold the dominant share of the market during the forecast period. This growth is primarily attributed to the higher proportion of females undergoing cosmetic procedures.

  • For instance, as per the data provided by SpaMedica in December 2023, around 9.2 million Botox procedures were performed globally in 2022. Out of these, 85.1% of botox procedures were done on females, and only 14.9% of botox procedures were done on males.

Additionally, the male segment is anticipated to grow considerably throughout the forecast period. The considerable growth in the number of male patients undergoing non-surgical cosmetic treatments to enhance their appearance is one of the major factors driving the segmental growth during.

  • For example, as per the data provided by the International Society of Aesthetic Plastic Surgery in June 2024, around 302,579 hair removal and 135,648 non-surgical skin tightening procedures were performed on males in 2023 over the globe.

By Age Group

35 to 50 Years Age Group Highly Adopt Non-surgical Cosmetic Treatment Owing to their Body Consciousness

Based on age group, the market is categorized into 18 years & younger, 19 to 34 years, 35 to 50 years, 51 to 64 years, and 65 years and above.

The 35 to 50 years segment dominated the global market in 2024 and is expected to grow at the highest CAGR during the forecast period. This is primarily attributed to the fact that the population aged between 35 to 50 years is more likely to opt for cosmetic treatments than other age groups. Furthermore, this age group is also more likely to be body-conscious and aesthetically focused, making them key consumers of both non-invasive cosmetic procedures.

  • According to the data published by the International Society of Aesthetic Plastic Surgery in June 2024, approximately 4.4 million people aged between 35–50 years went for Botox treatment worldwide.

On the other hand, the 19 to 34 years segment is expected to grow at the second-largest CAGR from 2025-2032. The growth of the segment is mainly attributed to the fact that this age group is more prone to adopt new technologies and procedures as they have a higher impact of social media.

Furthermore, the 51 to 64 years segment is expected to grow moderately during the forecast period. There is a shift in focus from surgical procedures to non-invasive options as individuals prioritize minimal downtime and quicker results. This age group also notices a growing interest in addressing signs of aging and maintaining a youthful appearance through treatments such as botulinum toxin and hyaluronic acid fillers.

By Provider

Hospitals & Specialty Clinics Lead as High Number of Cosmetic Procedures are Performed at these Facilities

Based on provider, the market is divided into hospitals & specialty clinics and spas & cosmetic surgery centers.

The hospitals & specialty clinics segment dominated the market by accounting for the major global non-surgical cosmetic procedures market share in 2024. This is primarily attributed to the increasing number of inpatient and outpatient admissions in hospitals & specialty clinics, along with the growing demand for minimally invasive procedures.

  • For example, as per the data provided by the International Society of Aesthetic Plastic Surgery in September 2023, nearly 47.4% of cosmetic procedures were carried out in hospitals and 31.1% in specialty clinics worldwide in 2022.

On the other hand, the spas & cosmetic surgery centers segment is expected to grow at a considerable CAGR throughout the forecast period. The growth of the segment is mainly attributed to the increasing number of medical spas and cosmetic surgery centers across the globe.

  • For example, as per the data provided by the American Society for Dermatologic Surgery, Inc., in October 2023, the growth of medical spas in the U.S. is exponential. In 2021, the American Medical Spa Association (AmSPA) reported 7,430 spas in the U.S., which increased to 8,841 spas in 2022.

NON-SURGICAL COSMETIC PROCEDURES MARKET REGIONAL OUTLOOK

In terms of regions, the global market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America

North America Non-Surgical Cosmetic Procedures Market Size, 2024 (USD Billion)

To get more information on the regional analysis of this market, Download Free sample

North America dominated the global market in 2024 with revenue of USD 5.72 billion and accounted for 49.6% market share. The growth of the market in this region was mainly attributed to the presence of advanced healthcare infrastructure, availability of numerous licensed practitioners, and increasing acceptance of aesthetic procedures. Moreover, the increasing launch of cosmetic products used to provide non-surgical cosmetic procedures is one of the important factors driving market growth in the U.S.

  • For example, in February 2021, Merz Aesthetics announced the launch of BELOTERO BALANCE (+), the lidocaine formulation of BELOTERO BALANCE in the U.S. market. This injectable filler is used to reduce wrinkles in the lower face.

Europe

Europe accounted for the second-largest share of the market in 2024, owing to the increasing initiatives by government authorities to implement regulations and offer schemes to assure consumers about the safety of non-surgical procedures.

  • For example, in April 2022, the Health and Care Act provided by the U.K. government authorities gave the Secretary of State for Health and Social Care the power to introduce a licensing regime for non-surgical cosmetic procedures in England. The scheme aims to ensure that consumers who choose to undergo a non-surgical cosmetic procedure can ensure that the treatment they receive is safe and of a high standard.

Asia Pacific

Asia Pacific held a moderate market share in 2024 and is anticipated to grow moderately throughout the forecast period. The growth of this region is primarily attributed to the increasing market players' focus on providing cosmetic products to enhance aesthetics.

  • For instance, in August 2022, Allergan Healthcare India announced the launch of Juvéderm VOLUX, an injectable implant used to restore and create the volume of face in the Indian market.

Latin America and the Middle East & Africa

The non-surgical cosmetic procedures market in Latin America and the Middle East & Africa is expected to grow steadily throughout the forecast period. The market growth in these regions is mainly attributed to the developing healthcare infrastructure and the higher number of non-surgical cosmetic procedures performed.

  • For example, as per the data provided by the International Society of Aesthetic Plastic Surgery in June 2024, nearly 1.2 million non-surgical cosmetic procedures were performed in 2023 in Brazil.

COMPETITIVE LANDSCAPE

Key Industry Players

Players Focus on Attending Medical Conferences to Expand Brand Presence Globally

The market consists of key companies such as AbbVie Inc., REVANCE, MERZ AESTHETICS, and GALDERMA, among others, involved in providing an extensive range of cosmetic products for non-surgical cosmetic surgeries. The rising market players' focus on attending medical conferences to create product awareness among consumers is one of the important factors contributing to their higher position in the global market.

  • For instance, in January 2025, AbbVie Inc. announced its presence at the International Master Course on Aging Science (IMCAS) World Congress 2024 in Paris from 30th January to 1st February 2025. During the event the company was present at Booth E130 to showcase its aesthetic products and create product awareness among customers.

Moreover, companies such as Sinclair, BIOXIS pharmaceuticals, Tiger Aesthetics Medical, LLC, Solta Medical, and Prollenium Medical Technologies are entering into strategic collaborations and acquisitions to expand their geographic footprint in the global market.

List of Key Non-Surgical Cosmetic Procedures Companies Profiled

  • AbbVie Inc. (U.S.)
  • REVANCE (U.S.)
  • MERZ AESTHETICS (U.S.)
  • GALDERMA (Switzerland)
  • Sinclair (U.S.)
  • BIOXIS pharmaceuticals (France)
  • Tiger Aesthetics Medical, LLC (U.S.)
  • Solta Medical (U.S.)
  • Prollenium Medical Technologies (Canada)
  • WiQo S.p.A. (Italy)

KEY INDUSTRY DEVELOPMENTS

  • February 2025 - Evolus, Inc., received the U.S. Food and Drug Administration (FDA) approval for its Evolysse Form and Evolysse Smooth injectable hyaluronic acid (HA) gels used to treat facial wrinkles and nasolabial folds. With this approval, the company started providing these products in the U.S. market.
  • September 2024 - Allergan Aesthetics, an AbbVie company, announced that its BOTOX Cosmetic (onabotulinumtoxinA) product is available for the treatment of masseter muscle prominence (MMP) in China.
  • March 2023 - Givaudan Active Beauty announced the launch of PrimalHyal Hydra[+], a new cationic hyaluronic acid (HA) in the global market.
  • December 2022 - Gufic Biosciences announced the launch of Zarbot Botox injection in the Indian market.
  • March 2021 - dsm-firmenich, a global science-based company active in nutrition, health, and sustainable living, announced the launch of three different forms of hyaluronic acid. With the new HYA-ACT range, the company strengthened its hyaluronic acid portfolio to meet market expectations for less invasive, reliable, and effective beauty care solutions.

REPORT COVERAGE

The global non-surgical cosmetic procedures market report provides a detailed competitive landscape and market insights. In addition to the market size, it covers regional analysis of different market segments, profiles of key market players, and market dynamics. Moreover, the market report encompasses several factors that have contributed to the growth of the market over recent years.

To gain extensive insights into the market, Download for Customization

REPORT SCOPE & SEGMENTATION

ATTRIBUTE

DETAILS

Study Period

2019-2032

Base Year

2024

Estimated Year

2025

Forecast Period

2025-2032

Historical Period

2019-2023

Growth Rate

CAGR of 5.8% from 2025-2032

Unit

Value (USD billion)

Segmentation

By Procedure

  • Botulinum Toxin
  • Hyaluronic Acid
  • Hair Removal
  • Non-surgical Fat Reduction
  • Photo Rejuvenation
  • Others

By Gender

  • Male
  • Female

By Age Group

  • 18 Years & Younger
  • 19 to 34 Years
  • 35 to 50 Years
  • 51 to 64 Years
  • 65 Years and Above

By Provider

  • Hospitals & Specialty Clinics
  • Spas & Cosmetic Surgery Centers

By Region

  • North America (By Procedure, Gender, Age Group, Provider, and Country/Sub-Region)
    • U.S.
    • Canada
  • Europe (By Procedure, Gender, Age Group, Provider, and Country/Sub-Region)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Procedure, Gender, Age Group, Provider, and Country/Sub-Region)
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Procedure, Gender, Age Group, Provider, and Country/Sub-Region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Procedure, Gender, Age Group, Provider, and Country/Sub-Region)
    • GCC
    • South Africa
    • Rest of the Middle East & Africa


Frequently Asked Questions

Fortune Business Insights says that the global market stood at USD 11.53 billion in 2024 and is projected to reach USD 18.08 billion by 2032.

In 2024, North America’s market value stood at USD 5.72 billion.

The market will exhibit steady growth at a CAGR of 5.8% during the forecast period (2025-2032).

By procedure, the botulinum toxin segment led the market.

The high burden of skin disorders and the rising number of non-surgical cosmetic procedures are some of the important factors driving market growth.

AbbVie Inc., REVANCE, MERZ AESTHETICS, and GALDERMA are the major players operating in the market.

Seeking Comprehensive Intelligence on Different Markets?Get in Touch with Our Experts Speak to an Expert
  • 2019-2032
  • 2024
  • 2019-2023
  • 158
Download Free Sample

    man icon
    Mail icon
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Healthcare Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann